Yin yang 1 plays an essential role in breast cancer and negatively regulates p27

American Journal of Pathology

Volumn 180, Issue 5, 2012, Pages 2120-2133

  Wan, Meimei ^a   Huang, Weiwei ^a,b   Kute, Timothy E ^a   Miller, Lance D ^a   Zhang, Qiang ^a   Hatcher, Heather ^a   Wang, Jingxuan ^c   Stovall, Daniel B ^a   Russell, Gregory B ^a   Cao, Paul D ^a   Deng, Zhiyong ^a   Wang, Wei ^a   Zhang, Qingyuan ^c   Lei, Ming ^b   Torti, Suzy V ^a   Akman, Steven A ^a   Sui, Guangchao ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NORTHWEST A F UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN P27; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR YY1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOARCHITECTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN PROCESSING, POST-TRANSLATIONAL; REAL-TIME POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UP-REGULATION; YY1 TRANSCRIPTION FACTOR;

EID: 84860238252     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.01.037     Document Type: Article

References (72)

1. H.T. Bjornsson, M.D. Fallin, A.P. Feinberg An integrated epigenetic and genetic approach to common human disease Trends Genet 20 2004 350 358
2. C.X. Deng BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution Nucleic Acids Res 34 2006 1416 1426
3. L. Kopelovich, J.A. Crowell, J.R. Fay The epigenome as a target for cancer chemoprevention J Natl Cancer Inst 95 2003 1747 1757
4. A. Catteau, J.R. Morris BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol 12 2002 359 371
5. Y. Shi, E. Seto, L.S. Chang, T. Shenk Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein Cell 67 1991 377 388
6. Y. Shi, J.S. Lee, K.M. Galvin Everything you have ever wanted to know about Yin Yang 1 Biochim Biophys Acta 1332 1997 F49 F66
7. G. Sui The regulation of YY1 in tumorigenesis and its targeting potential in cancer therapy Mol Cell Pharmacol 1 2009 157 176
8. Q. Zhang, D.B. Stovall, K. Inoue, G. Sui The oncogenic role of Yin Yang 1 Crit Rev Oncog 16 2011 163 197
9. M.J. Thomas, E. Seto Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236 1999 197 208
10. S. Gordon, G. Akopyan, H. Garban, B. Bonavida Transcription factor YY1: architecture, function, and therapeutic implications in cancer biology Oncogene 25 2006 1125 1142
11. L. Atchison, A. Ghias, F. Wilkinson, N. Bonini, M.L. Atchison Transcription factor YY1 functions as a PcG protein in vivo EMBO J 22 2003 1347 1358
12. J.L. Brown, D. Mucci, M. Whiteley, M.L. Dirksen, J.A. Kassis The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1 Mol Cell 1 1998 1057 1064
13. L. Wang, J.L. Brown, R. Cao, Y. Zhang, J.A. Kassis, R.S. Jones Hierarchical recruitment of polycomb group silencing complexes Mol Cell 14 2004 637 646
14. N. Sankar, S. Baluchamy, R.K. Kadeppagari, G. Singhal, S. Weitzman, B. Thimmapaya p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc Oncogene 27 2008 5717 5728
15. Q. Zhou, R.W. Gedrich, D.A. Engel Transcriptional repression of the c-Fos gene by YY1 is mediated by a direct interaction with ATF/CREB J Virol 69 1995 4323 4330
16. J.S. Lee, K.M. Galvin, R.H. See, R. Eckner, D. Livingston, E. Moran, Y. Shi Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300 Genes Dev 9 1995 1188 1198
17. W.M. Yang, C. Inouye, Y. Zeng, D. Bearss, E. Seto Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3 Proc Natl Acad Sci USA 93 1996 12845 12850
18. G. Caretti, M. Di Padova, B. Micales, G.E. Lyons, V. Sartorelli The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation Genes Dev 18 2004 2627 2638
19. G. Sui, B. Affar el, Y. Shi, C. Brignone, N.R. Wall, P. Yin, M. Donohoe, M.P. Luke, D. Calvo, S.R. Grossman, Y. Shi Yin Yang 1 is a negative regulator of p53 Cell 117 2004 859 872
20. V. Petkova, M.J. Romanowski, I. Sulijoadikusumo, D. Rohne, P. Kang, T. Shenk, A. Usheva Interaction between YY1 and the retinoblastoma protein: regulation of cell cycle progression in differentiated cells J Biol Chem 276 2001 7932 7936
21. J.T. Cunningham, J.T. Rodgers, D.H. Arlow, F. Vazquez, V.K. Mootha, P. Puigserver mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex Nature 450 2007 736 740
22. E. Gronroos, A.A. Terentiev, T. Punga, J. Ericsson YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress Proc Natl Acad Sci USA 101 2004 12165 12170
23. D.Y. Begon, L. Delacroix, D. Vernimmen, P. Jackers, R. Winkler Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells J Biol Chem 280 2005 24428 24434
24. A. Allouche, G. Nolens, A. Tancredi, L. Delacroix, J. Mardaga, V. Fridman, R. Winkler, J. Boniver, P. Delvenne, D.Y. Begon The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors Breast Cancer Res 10 2008 R9
25. D. Harari, Y. Yarden Molecular mechanisms underlying ErbB2/HER2 action in breast cancer Oncogene 19 2000 6102 6114
26. W. Huang, P.J. Smaldino, Q. Zhang, L.D. Miller, P. Cao, K. Stadelman, M. Wan, B. Giri, M. Lei, Y. Nagamine, J.P. Vaughn, S.A. Akman, G. Sui Yin Yang 1 contains G-quadruplex architectures in its promoter and 5′-UTR and its expression is modulated by G4 resolvase 1 Nucleic Acids Res 40 2011 1033 1049
27. A. Zaravinos, D.A. Spandidos Yin Yang 1 expression in human tumors Cell Cycle 9 2010 512 522
28. G. Castellano, E. Torrisi, G. Ligresti, G. Malaponte, L. Militello, A.E. Russo, J.A. McCubrey, S. Canevari, M. Libra The involvement of the transcription factor Yin Yang 1 in cancer development and progression Cell Cycle 8 2009 1367 1372
29. H. Niwa, K. Yamamura, J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 1991 193 199
30. G. Sui, C. Soohoo, B. Affar el, F. Gay, Y. Shi, W.C. Forrester, Y. Shi A DNA vector-based RNAi technology to suppress gene expression in mammalian cells Proc Natl Acad Sci USA 99 2002 5515 5520
31. G. Sui, Y. Shi Gene silencing by a DNA vector-based RNAi technology Methods Mol Biol 309 2005 205 218
32. B. Elenbaas, L. Spirio, F. Koerner, M.D. Fleming, D.B. Zimonjic, J.L. Donaher, N.C. Popescu, W.C. Hahn, R.A. Weinberg Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells Genes Dev 15 2001 50 65
33. H.D. Soule, T.M. Maloney, S.R. Wolman, W.D. Peterson Jr, R. Brenz, C.M. McGrath, J. Russo, R.J. Pauley, R.F. Jones, S.C. Brooks Isolation and characterization of a spontaneously immortalized human breast epithelial cell line MCF-10. Cancer Res 50 1990 6075 6086
34. R.B. Dickson, S.E. Bates, M.E. McManaway, M.E. Lippman Characterization of estrogen responsive transforming activity in human breast cancer cell lines Cancer Res 46 1986 1707 1713
35. R. Cailleau, M. Olive, Q.V. Cruciger Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization In Vitro 14 1978 911 915
36. D.A. Rubinson, C.P. Dillon, A.V. Kwiatkowski, C. Sievers, L. Yang, J. Kopinja, D.L. Rooney, M.M. Ihrig, M.T. McManus, F.B. Gertler, M.L. Scott, L. Van Parijs A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference Nat Genet 33 2003 401 406
37. B.L. Stackhouse, H. Williams, P. Berry, G. Russell, P. Thompson, J.L. Winter, T. Kute Measurement of glut-1 expression using tissue microarrays to determine a race-specific prognostic marker for breast cancer Breast Cancer Res Treat 93 2005 247 253
38. J.L. Winter, B.L. Stackhouse, G.B. Russell, T.E. Kute Measurement of PTEN expression using tissue microarrays to determine a race-specific prognostic marker in breast cancer Arch Pathol Lab Med 131 2007 767 772
39. P. Cao, Z. Deng, M. Wan, W. Huang, S.D. Cramer, J. Xu, M. Lei, G. Sui MicroRNA-101 negatively regulates Ezh2, and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta Mol Cancer 9 2010 108
40. K.L. Burger, A.L. Davis, S. Isom, N. Mishra, D.F. Seals The podosome marker protein Tks5 regulates macrophage invasive behavior Cytoskeleton (Hoboken) 68 2011 694 711
41. G. Benton, J. George Defining 3-D culture for investigating breast cancer progression Biosci Technol 1 2005 50 52
42. J. Debnath, S.K. Muthuswamy, J.S. Brugge Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures Methods 30 2003 256 268
43. M.M. Tomayko, C.P. Reynolds Determination of subcutaneous tumor size in athymic (nude) mice Cancer Chemother Pharmacol 24 1989 148 154
44. K.J. Livak, T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔ CT Method Methods 25 2001 402 408
45. Z. Deng, M. Wan, G. Sui PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger Mol Cell Biol 27 2007 3780 3792
46. Y. Pan, J. Chen MDM2 promotes ubiquitination and degradation of MDMX Mol Cell Biol 23 2003 5113 5121
47. C.G. Kleer, Q. Cao, S. Varambally, R. Shen, I. Ota, S.A. Tomlins, D. Ghosh, R.G. Sewalt, A.P. Otte, D.F. Hayes, M.S. Sabel, D. Livant, S.J. Weiss, M.A. Rubin, A.M. Chinnaiyan EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells Proc Natl Acad Sci USA 100 2003 11606 11611
48. S. Calza, P. Hall, G. Auer, J. Bjohle, S. Klaar, U. Kronenwett, E.T. Liu, L. Miller, A. Ploner, J. Smeds, J. Bergh, Y. Pawitan Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients Breast Cancer Res 8 2006 R34
49. A.S. Cheng, A.C. Culhane, M.W. Chan, C.R. Venkataramu, M. Ehrich, A. Nasir, B.A. Rodriguez, J. Liu, P.S. Yan, J. Quackenbush, K.P. Nephew, T.J. Yeatman, T.H. Huang Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome Cancer Res 68 2008 1786 1796
50. L.D. Miller, J. Smeds, J. George, V.B. Vega, L. Vergara, A. Ploner, Y. Pawitan, P. Hall, S. Klaar, E.T. Liu, J. Bergh An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc Natl Acad Sci USA 102 2005 13550 13555
51. M. Bain, J. Sinclair Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death Eur J Cell Biol 84 2005 543 553
52. F.S. Santiago, H. Ishii, S. Shafi, R. Khurana, P. Kanellakis, R. Bhindi, M.J. Ramirez, A. Bobik, J.F. Martin, C.N. Chesterman, I.C. Zachary, L.M. Khachigian Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly Circ Res 101 2007 146 155
53. T. Yakovleva, L. Kolesnikova, V. Vukojevic, I. Gileva, K. Tan-No, M. Austen, B. Luscher, T.J. Ekstrom, L. Terenius, G. Bakalkin YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription Biochem Biophys Res Commun 318 2004 615 624
54. L. Baker, P.R. Quinlan, N. Patten, A. Ashfield, L.J. Birse-Stewart-Bell, C. McCowan, J.C. Bourdon, C.A. Purdie, L.B. Jordan, J.A. Dewar, L. Wu, A.M. Thompson p53 mutation, deprivation and poor prognosis in primary breast cancer Br J Cancer 102 2010 719 726
55. A. Alkarain, J. Slingerland Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer Breast Cancer Res 6 2004 13 21
56. X. Guan, Y. Wang, R. Xie, L. Chen, J. Bai, J. Lu, M.T. Kuo p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysis J Cell Mol Med 14 2010 944 953
57. B. Belletti, I. Pellizzari, S. Berton, L. Fabris, K. Wolf, F. Lovat, M. Schiappacassi, S. D'Andrea, M.S. Nicoloso, S. Lovisa, M. Sonego, P. Defilippi, A. Vecchione, A. Colombatti, P. Friedl, G. Baldassarre p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling Mol Cell Biol 30 2010 2229 2240
58. A.M. Abukhdeir, B.H. Park P21 and p27: roles in carcinogenesis and drug resistance Expert Rev Mol Med 10 2008 e19
59. I. Chu, J. Sun, A. Arnaout, H. Kahn, W. Hanna, S. Narod, P. Sun, C.K. Tan, L. Hengst, J. Slingerland p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2 Cell 128 2007 281 294
60. A.C. Carrano, E. Eytan, A. Hershko, M. Pagano SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nat Cell Biol 1 1999 193 199
61. L.M. Tsvetkov, K.H. Yeh, S.J. Lee, H. Sun, H. Zhang p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27 Curr Biol 9 1999 661 664
62. D.G. Powe, G. Akhtar, H.O. Habashy, T. Abdel-Fatah, E.A. Rakha, A.R. Green, I.O. Ellis Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification Breast Cancer Res 11 2009 R90
63. D. Seligson, S. Horvath, S. Huerta-Yepez, S. Hanna, H. Garban, A. Roberts, T. Shi, X. Liu, D. Chia, L. Goodglick, B. Bonavida Expression of transcription factor Yin Yang 1 in prostate cancer Int J Oncol 27 2005 131 141
64. C.M. Nelson, M.J. Bissell Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation Semin Cancer Biol 15 2005 342 352
65. K.J. Martin, D.R. Patrick, M.J. Bissell, M.V. Fournier Prognostic breast cancer signature identified from 3-D culture model accurately predicts clinical outcome across independent datasets PLoS One 3 2008 e2994
66. F. Ciardiello, M. Gottardis, F. Basolo, S. Pepe, N. Normanno, R.B. Dickson, A.R. Bianco, D.S. Salomon Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells Mol Carcinog 6 1992 43 52
67. M. Dimri, M. Naramura, L. Duan, J. Chen, C. Ortega-Cava, G. Chen, R. Goswami, N. Fernandes, Q. Gao, G.P. Dimri, V. Band, H. Band Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar architecture and invasive behavior Cancer Res 67 2007 4164 4172
68. Z. Deng, M. Wan, P. Cao, A. Rao, S.D. Cramer, G. Sui Yin Yang 1 regulates the transcriptional activity of androgen receptor Oncogene 28 2009 3746 3757
69. Z. Deng, P. Cao, M. Wan, G. Sui Yin Yang 1: a multifaceted protein beyond a transcription factor Transcription 1 2010 81 84
70. J. Vervoorts, B. Luscher Post-translational regulation of the tumor suppressor p27(KIP1) Cell Mol Life Sci 65 2008 3255 3264
71. C.C. Wang, M.F. Tsai, T.H. Dai, T.M. Hong, W.K. Chan, J.J. Chen, P.C. Yang Synergistic activation of the tumor suppressor HLJ1 by the transcription factors YY1 and activator protein 1 Cancer Res 67 2007 4816 4826
72. M.H. Lee, T. Lahusen, R.H. Wang, C. Xiao, X. Xu, Y.S. Hwang, W.W. He, Y. Shi, C.X. Deng Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation Oncogene 31 2012 116 127